| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $1.06B+41.0% | $749.0M+48.4% | $504.9M |
| Cost of revenue | $185.5M+112.0% | $87.5M+96.7% | $44.5M |
| Gross profit | $870.3M+31.6% | $661.5M+43.7% | $460.4M |
| Research and development | $1.03B+37.1% | $751.1M+355.8% | $164.8M |
| Sales and marketing | $575.5M+21.9% | $472.1M+134.4% | $201.4M |
| General and administrative | $555.5M+75.9% | $315.7M+88.3% | $167.7M |
| Total operating expenses | $2.16B+40.4% | $1.54B+188.3% | $533.8M |
| Loss from operations | -$1.29B-47.1% | -$877.4M-1094.5% | -$73.5M |
| Other income, net | $64.8M-23.2% | $84.4M-91.7% | $1.02B |
| Income (loss) before income taxes | -$1.23B-54.5% | -$793.1M-183.8% | $945.9M |
| Provision for (benefit from) income taxes | $24.8M+140.7% | -$61.0M-129.3% | $208.1M |
| Net income (loss) | -$1.25B-70.8% | -$732.1M-199.2% | $737.8M |
| Less: net income attributable to participating securities | $0 | $0+100.0% | -$452.0M |
| Net income (loss) attributable to common stockholders | -$1.25B-70.8% | -$732.1M-356.1% | $285.9M |
| Net income (loss) per share, basic (in usd per share) | -$3710.00+0.8% | -$3740.00-320.0% | $1700.00 |
| Net income (loss) per share, diluted (in usd per share) | -$3710.00+0.8% | -$3740.00-330.9% | $1620.00 |
| Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, basic (in shares) | $337044000.00+72.3% | $195612000.00+16.2% | $168399000.00 |
| Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) | $337044000.00+72.3% | $195612000.00+4.5% | $187207000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.